Methods And Compositions Involving Mirna And Mirna Inhibitor Molecules

Patent No. EP2302055 (titled "Methods And Compositions Involving Mirna And Mirna Inhibitor Molecules") was filed by Asuragen on Nov 14, 2005. The application was issued on Aug 27, 2014.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SIMPSON, ALISON URQUHART-DYKES&LORD LLPMay 27, 2015GREEN
STRAWMANMay 26, 2015MURRAY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2302055

ASURAGEN
Application Number
EP10183577A
Filing Date
Nov 14, 2005
Status
Revoked
Jan 19, 2018
Publication Date
Aug 27, 2014